Hendy Geoffrey N, Goltzman David
Departments of Medicine, Physiology and Human Genetics, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.
Curr Opin Nephrol Hypertens. 2005 Jul;14(4):350-4. doi: 10.1097/01.mnh.0000172721.44875.24.
Although the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D), is classically appreciated to exert its calcemic and other actions via interaction with the vitamin D receptor, thereby modulating gene transcription, some of its actions cannot be explained in this way when examined in vitro.
Comparison of mouse models deleted for either the 25-hydroxyvitamin D-1alpha-hydroxylase enzyme (deficient in 1,25(OH)2D) or the vitamin D receptor or both has allowed an assessment of whether 1,25(OH)2D can function in the absence of the vitamin D receptor in vivo. The data indicated that calcium absorption required both the ligand and the receptor as did bone and cartilage remodeling. However, with respect to parathyroid gland function and development of the cartilaginous growth plate, calcium and 1,25(OH)2D acted cooperatively and there was evidence that 1,25(OH)2D could act independently of the vitamin D receptor.
Results from the genetic models are consistent with recent reports that rapid actions of vitamin D metabolites occur in chondrocytes through a membrane receptor distinct from the vitamin D receptor. In addition, in osteoblasts it has been proposed that the vitamin D receptor localized in plasma membrane caveolae signals the rapid effects of the active vitamin D secosterol.
尽管维生素D的活性代谢产物1,25 - 二羟基维生素D(1,25(OH)2D)传统上被认为是通过与维生素D受体相互作用来发挥其血钙调节及其他作用,从而调节基因转录,但在体外研究时,其一些作用无法用这种方式解释。
对缺失25 - 羟基维生素D - 1α - 羟化酶(缺乏1,25(OH)2D)、维生素D受体或两者的小鼠模型进行比较,使得能够评估1,25(OH)2D在体内缺乏维生素D受体时是否能发挥作用。数据表明,钙吸收以及骨骼和软骨重塑都需要配体和受体。然而,关于甲状旁腺功能和软骨生长板的发育,钙和1,25(OH)2D协同发挥作用,并且有证据表明1,25(OH)2D可以独立于维生素D受体发挥作用。
基因模型的结果与最近的报道一致,即维生素D代谢产物在软骨细胞中通过一种不同于维生素D受体的膜受体产生快速作用。此外,在成骨细胞中,有人提出定位于质膜小窝的维生素D受体介导了活性维生素D甾醇的快速作用。